OBJECTIVES/HYPOTHESIS: Laryngopharyngeal reflux is a common event in patients with head and neck cancer. Bile acid is known to be related to tumor formation in the esophagus through the overexpression of cyclo-oxygenase-2 (COX-2), an enzyme that produces prostanoids. To better understand the mechanism of the laryngopharyngeal reflux-cancer connection, we examined COX-2 expression by bile acid in cultured human pharyngeal mucosa cells. METHODS: COX-2 expression induction by various combinations of chenodeoxycholate and acidity was observed by Western blotting and reverse transcriptase-polymerase chain reaction. COX-2 promoter activity was also measured by luciferase promoter assay. RESULTS: Chenodeoxycholate, one of the bile acid components, was found to induce COX-2 expression in human pharyngeal cells. Moreover, the induction of COX-2 by chenodeoxycholate was enhanced by acidity in a dose-dependent manner, and the promoter activity of COX-2 was increased by chenodeoxycholate in SNU-1041, a human laryngeal cancer cell line, whereas the transcription of COX-2 was inhibited by actinomycin-D. CONCLUSION: Bile salts or acidic conditions, or both, can induce COX-2 expression in normal pharyngeal mucosa, which implies that laryngopharyngeal reflux has a role in the tumorigenesis of the upper aerodigestive tract.
OBJECTIVES/HYPOTHESIS: Laryngopharyngeal reflux is a common event in patients with head and neck cancer. Bile acid is known to be related to tumor formation in the esophagus through the overexpression of cyclo-oxygenase-2 (COX-2), an enzyme that produces prostanoids. To better understand the mechanism of the laryngopharyngeal reflux-cancer connection, we examined COX-2 expression by bile acid in cultured human pharyngeal mucosa cells. METHODS: COX-2 expression induction by various combinations of chenodeoxycholate and acidity was observed by Western blotting and reverse transcriptase-polymerase chain reaction. COX-2 promoter activity was also measured by luciferase promoter assay. RESULTS:Chenodeoxycholate, one of the bile acid components, was found to induce COX-2 expression in human pharyngeal cells. Moreover, the induction of COX-2 by chenodeoxycholate was enhanced by acidity in a dose-dependent manner, and the promoter activity of COX-2 was increased by chenodeoxycholate in SNU-1041, a humanlaryngeal cancer cell line, whereas the transcription of COX-2 was inhibited by actinomycin-D. CONCLUSION: Bile salts or acidic conditions, or both, can induce COX-2 expression in normal pharyngeal mucosa, which implies that laryngopharyngeal reflux has a role in the tumorigenesis of the upper aerodigestive tract.
Authors: Scott M Langevin; Dominique S Michaud; Carmen J Marsit; Heather H Nelson; Ariel E Birnbaum; Melissa Eliot; Brock C Christensen; Michael D McClean; Karl T Kelsey Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05-23 Impact factor: 4.254
Authors: Eugenio De Corso; Silvia Baroni; Stefania Agostino; Giovanni Cammarota; Giovanni Mascagna; Alice Mannocci; Mario Rigante; Jacopo Galli Journal: Ann Surg Date: 2007-06 Impact factor: 12.969
Authors: Nikki Johnston; Justin C Yan; Craig R Hoekzema; Tina L Samuels; Gary D Stoner; Joel H Blumin; Jonathan M Bock Journal: Laryngoscope Date: 2012-05-08 Impact factor: 3.325